Current and developing chemotherapy for CLL.
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 19 (2) , S11-S20
- https://doi.org/10.1385/mo:19:2s:s11
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Multicenter Phase II Study of Oral Idarubicin in Treated and Untreated Patients with B-Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2000
- Chronic lymphocytic leukemia.1999
- Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.1998
- Clinical challenges in chronic lymphocytic leukemia.1998
- Chlorambucil in Indolent Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1998
- Idarubicin in low-grade non-Hodgkin's lymphomas.1997
- Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis ResistanceMolecular Pharmacology, 1997
- Chronic lymphocytic leukemia: a changing natural history?Leukemia, 1997
- Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.Journal of Clinical Oncology, 1994
- Is the CHOP Regimen a Good Treatment for Advanced CLL? Results from two Randomized Clinical TrialsLeukemia & Lymphoma, 1994